Skip to content
buyWeak

Jonathan H Kaufman bought $7,590 of LIPO

See remarks below. at LIPELLA PHARMACEUTICALS INC. 10,000 shares at an average of $0.76, traded May 14, 2024, filed May 15, 2024.

Conviction score
28
Value
$7,590
10,000 shares
Holdings after
898,849
+1% from before
From 52-week low
+11%
low $5.39, close $6.00
From 52-week high
-67%
high $18.00, as of May 14, 2024

Score components

  • Role
    Officer
    +15
  • Trade size
    $8k at market
    0
  • Relative to holdings
    Holdings up 1.1%
    0
  • Price context
    67% below the 52-week high
    +8
  • Cluster
    No other insider buying within 14 days
    0
  • Repeat buying
    2 buys in 90 days
    +5
  • Track record
    Too few past buys to judge (0 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m -10.9%, 3m -42.9%, 6m -56.8%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

LIPOOct 12, 2026 · close 0.00
Since filing May 15, 2024: -100.0%SPY +51.2% · excess -151.2%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001753926-24-000984, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
May 14, 2024POpen-market purchase
Common Stock
+10,000$0.76$7,590898,849May 15, 2024

Related signals

Other insiders at LIPELLA PHARMACEUTICALS INC and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
32Weak
LIPObuy
LIPELLA PHARMACEUTICALS INC
Jonathan H Kaufman
See remarks below.
$45k
55,000 shares
+7%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Jonathan H Kaufman bought $7,590 of LIPO | InsiderTell